Emkay Research has issued a BUY recommendation on Metropolis Healthcare, setting a 12-month target price of Rs 2,050.

Emkay Research has initiated coverage on HDB Financial Services (HDBFS) with a resolute BUY call and a 12-month target price of Rs900, representing a 22% upside from the current market price of Rs7

Emkay Research, in its latest update dated June 24, 2025, has maintained a BUY rating on Metro Brands, setting a 12-month target price of Rs1,400—implying an upside of nearly 22% from current level

Emkay Research has reiterated a BUY Call on Tata Motors, albeit with a trimmed 12-month target price of Rs 750, reflecting a cautious yet constructive stance amid evolving global automotive dynamic

Emkay Research has reiterated its BUY recommendation on Axis Bank, setting a 12-month target price of Rs 1,400, which represents a potential upside of 15.2% from the current market price of Rs 1,21

Emkay Global Financial Services has reaffirmed its BUY rating on Indian Bank (INBK) with a 12-month target price of Rs 675, signaling 6.5% upside from current levels.